TradeFlare's AI research teams analysed MLYS on 7 market nights between May 25, 2026 and September 11, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| September 11, 2026 | BUY | $29.30 | $35.16 / $24.91 | -0.6% | -17.1% | The PDUFA date for lorundrostat is in late 2026, suggesting a medium-term catalyst. |
| September 10, 2026 | BUY | $30.50 | $36.60 / $25.93 | -4.5% | -23.6% | The post-earnings drift suggests momentum that can sustain for several weeks. |
| September 9, 2026 | HOLD | $31.12 | — / — | -9.7% | -27.6% | The current market regime and the stock's neutral technicals, coupled with high risk, necessitate a cautious approach. |
| September 8, 2026 | HOLD | $28.21 | — / — | -7.1% | -29.5% | The stock is being held due to significant risk factors and a lack of strong directional conviction. |
| September 7, 2026 | HOLD | $28.21 | — / — | -7.1% | -29.5% | The current market regime and the stock's technical setup do not warrant a buy at this time. |
| May 26, 2026 | BUY | $29.85 | $35.82 / $25.37 | -3.8% | -14.1% | The post-earnings drift pattern suggests a multi-week upward trend. |
| May 25, 2026 | SELL | $29.85 | — / — | -3.8% | -14.1% | FDA PDUFA target date for lorundrostat on December 22, 2026. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.